Petros Grivas, Clinical Director of the GU Cancer Program at the University of Washington, shared Binaytara’s post on X, adding:
“Always a pleasure co-chairing this amazing meeting with Dr. Zhen with stellar speakers, great interactions with colleagues, learning together!”
Quoting Binaytara’s post:
“Day one of Best of Oncology 2026 Seattle is underway. We’re covering the most compelling takeaways from ASCO26 and other recent cancer care data. If you’re in the room, share your reactions at Best of Oncology.
Day 1 Program: Hematologic Malignancies, General Oncology, Tumor-Board Style Discussion: Immunotherapy-Related Adverse Events.
This activity is independent and not affiliated with, sponsored by, or endorsed by the American Society of Clinical Oncology.”
Other articles featuring Dr. Grivas and Binaytara on OncoDaily.
